感谢您提供的信息。现在您可以查看该资源了。

Abbott Informatics SDMS Solution Helped ImClone Cut Costs and Boost Productivity

下载 (PDF321.0 KB)

2013年11月7日

Abbott Informatics SDMS Solution Helped ImClone Cut Costs and Boost Productivity

Company Background

ImClone, a wholly-owned subsidiary of Eli Lilly, is a leader in the research, development and manufacturing of oncology drugs. The manufacture of pharmaceutical products is a complex process requiring multiple validation checks necessary to ensure patients get a safe and efficacious product. ImClone has implemented rigorous testing processes to ensure manufactured lots meet stringent quality control standards. The quality control process takes samples off manufacturing lines and tests them against defined test processes to ensure all quality standards are met.

 

Challenge

Prior to implementing STARLIMS and STARLIMS SDMS in 2010, the ImClone testing laboratory utilized an entirely paper based system to track and manage test results. Samples would come into a lab and a paper requisition would capture what the sample was, how many vials were involved, and what testing was required, among other things. The paper requisition form would be passed along throughout the process documenting the chain of custody. Test results would be printed and attached to the sample submission as it went through the lab.

ImClone was forecasting tremendous growth in manufacturing, which would result in increasing demand on the testing department. The volume of paper based submissions was projected to increase 64%, while the lab would need to increase headcount by a projected 40% to handle the increased volume. The paper based process was difficult to scale to accommodate the increased volume and presented several challenges. First, processing paper is resource intensive and slows down turnaround time. In addition, paper makes it difficult for the lab to continue scaling up in response to the increased volume of manufacturing, without adding additional headcount. Finally, a paper process increases the risk of samples not getting tested properly, or being unnecessarily retested.

 

Solution

ImClone initiated a process to select a new automated Laboratory Information Management System (LIMS). After a thorough decision review process, ImClone selected STARLIMS and the STARLIMS Scientific Data Management System (SDMS) as best meeting its needs. STARLIMS offered a web based LIMS solution which would allow the automation of sample receipt and tracking throughout the laboratory process. In addition, the tight, seamless integration between STARLIMS and STARLIMS SDMS allows the centrally administered LIMS solution to process all types of data generated by instruments.

 

Benefits

ImClone resources and STARLIMS Professional Services worked together to implement the new automated process. The project successfully went live in January 2010. The new STARLIMS solution allowed ImClone to completely automate sample receipt and tracking throughout the testing department, and the SDMS component provided several additional benefits including reducing errors, increasing efficiency and boosting laboratory productivity.

STARLIMS SDMS reduces errors by providing all relevant sample data in one spot

STARLIMS SDMS pulls together paper and instrument data for each sample and makes it available to whoever needs it as the sample moves through the laboratory. All kinds of sample data, including raw instrument files, PDF files, csv files, and so on can be parsed via SDMS and attached to the sample submission in STARLIMS. This is a significant improvement because the data no longer needs to be attached by paper to the sample and tracked manually. Now data is easily accessible using a web based system with full traceability and is retrievable later as needed. The right data is available for each sample, and there is no longer an opportunity for reports to be mismatched to samples.

STARLIMS SDMS increases efficiency through paperless assays

ImClone was able to convert assays to be completely paperless. Not only did this cut down on paper costs, but the data is stored within the STARLIMS database, which means it can be retrieved at a later date if needed. STARLIMS SDMS provides full traceability and through powerful search features, technicians can find any information they need from the sample and files.

STARLIMS SDMS boosts laboratory productivity

Previously, reviewers had to be physically in the office to review the paperwork and sign off on sample submissions. But now, reviewers are able to review results remotely, during weekends, and off-hours because the test results are available via secure web browsing. Critical sample submissions can be reviewed and approved even if the reviewer is working from home or the review needs to happen on the weekend. The increased access significantly increases laboratory productivity.

 

Results

By implementing STARLIMS LIMS and SDMS solutions, ImClone was able to scale up volume by 25% without increasing headcount. A projected cost increase of 65% in printing, management, and storage was eliminated due to the automated data capture within STARLIMS SDMS which would store all data electronically. ImClone was able to save on paper and printing costs, archiving costs, additional time spent on managing paper forms, and storage space for storing the forms. And ImClone was able to reduce the average turnaround time for an Active Pharmaceutical Ingredient (API) test from 60 days to 28 days, a decrease of 53% so that the patients ImClone serves can get the drugs they need faster.

填写下表以查看更多信息。

"With STARLIMS SDMS, our reviewers no longer have to be on-site to review samples and data packages. Instead, STARLIMS SDMS allows us to have all instrument files and reports attached electronically to the sample submission and available for reviewers to review and approve on weekends and off-hours. This allows samples to be processed much faster."

Richard Caron
Associate Director, ImClone Systems

您即将退出面向第三方网站的 ABBOTT 系列网站

使您离开 Abbott 全球网站的链接不受 Abbott 控制;对于任何此类网站的内容或者来自此类网站的任何进一步链接,Abbott 概不负责。Abbott 向您提供这些链接仅为方便之用,包含任何链接并不意味着所链接的网站已获 Abbott 认可。您已请求的网站的屏幕尺寸对您而言也可能并非最佳尺寸。

您希望继续并进入该网站吗?

是的 没有

您将进入 Abbott 为某个特定国家或地区建立的网站。

请注意,您请求的网站适用于某一特定国家/地区或多个国家/地区的居民,具体如该网站所述。因此,该网站包含的信息可能涉及尚未在其他国家或地区获得批准的药品、医疗设备和其他产品或其用途。

您希望继续并进入该网站吗?

是的 没有

您将进入 Abbott 为某个特定国家或地区建立的网站。

请注意,您请求的网站适用于某一特定国家/地区或多个国家/地区的居民,具体如该网站所述。因此,该网站包含的信息可能涉及尚未在其他国家或地区获得批准的药品、医疗设备和其他产品或其用途。

您希望继续并进入该网站吗?

是的 没有

联系我们